Results 181 to 190 of about 4,666,601 (266)

Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases. [PDF]

open access: yesInt J Mol Sci, 2023
Jang J   +9 more
europepmc   +1 more source

Case Report: Diabetic ketoacidosis after co-administration of empagliflozin and probenecid [version 2; peer review: 2 approved, 1 approved with reservations]

open access: yesWellcome Open Research
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are filtered and secreted to their primary site of action in the proximal tubule of the kidney. At this site, SGLT2 inhibitors also reduce renal elimination of ketone bodies, a finding implicated in their
Niamh Reidy   +3 more
doaj  

Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance. [PDF]

open access: yesBMC Med, 2023
Sae-Jie W   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy